Andalusia intensifies clinical research in search of treatments against Covid-19
The Junta de Andalucía, through the Ministry of Health and Families, is going to launch a research program that contributes to generating scientific evidence of treatments for other pathologies that positively affect the prognosis of Covid-19.
For this purpose and through the Network of research management foundations, an agreement will be drawn up between local foundations, where the project's operating mechanisms and contributions will be established both in kind, through personnel who make themselves available, as well as capital for an estimated amount of 300.000 euros.
This program is aligned with the initiatives launched at national and European level and responds to the importance that clinical research currently has to reliably determine possible new uses for Covid-19 of medicines already authorized for other diseases.
Specifically, this extraordinary program aims to finance controlled research projects for therapeutic intervention in any of its phases (phase I, II or III clinical trials) or observational studies on the clinical impact of treatment strategies. The main objective is the generation of translational research that contributes to the improvement of clinical practice in patients with coronavirus.
In short, the Ministry of Health and Families seeks evidence of treatments that are already used for other diseases that improve the prognosis and evolution of patients with Covid-19 and is aimed at researchers from the Ancraid Network (Andalusian Clinical Research Network in infectious diseases), which brings together infectious disease specialists, microbiologists and intensivists, although it is a research program open to proposals from groups that wish to carry them out without necessarily participating in this network.
